NEW YORK (GenomeWeb) – Meridian Bioscience today reported that its first quarter revenues fell 2 percent year over year.

The company said revenues decreased to $47.2 million for the three months ended Dec. 31, 2015, from $48.0 million a year ago, missing analysts' consensus estimate of $48.6 million in revenues for the quarter.

However, the firm's net earnings for the quarter rose 13 percent to $8.9 million, or $.21 per share, compared to $7.9 million, or $.19 per share, for Q1 2015, and matched the consensus Wall Street estimate.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Berkeley researchers have engineered yeast to make the molecule behind the hoppy taste of beer, Quartz reports.

King's College London researchers examine the influence of school type and genetics on academic achievement.

FiveThirtyEight writes that most who take a direct-to-consumer BRCA1/2 genetic test won't learn much from it.

In Science this week: early life experience influence somatic variation in the genome, and more.